| Literature DB >> 35351531 |
Aamirah Mussa1, Kathleen M Powis2, Shahin Lockman3, Gbolahan Ajibola4, Chelsea Morroni5, Laura Smeaton6, Mompati Mmalane4, Joseph Makhema4, Roger L Shapiro7.
Abstract
We investigated the impact of prolonged cotrimoxazole prophylaxis on growth in 2848 HIV-exposed uninfected children enrolled in the Mpepu study, a randomized, placebo-controlled trial in Botswana. No significant differences in mean weight-for-age, length-for-age, or weight-for-length z scores between placebo and cotrimoxazole arms were observed overall through 18 months.Entities:
Keywords: HIV-exposed uninfected; antibiotics; child growth
Mesh:
Substances:
Year: 2022 PMID: 35351531 PMCID: PMC9233016 DOI: 10.1016/j.jpeds.2022.03.031
Source DB: PubMed Journal: J Pediatr ISSN: 0022-3476 Impact factor: 6.314